Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Project Code: 1729 | Other Identifier | General Services Administration (OES) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of California, Berkeley | OTHER |
| Abdul Latif Jameel Poverty Action Lab | OTHER |
| General Services Administration (GSA) | FED |
| Department of Health and Human Services |
Not provided
Not provided
Not provided
Not provided
This multi-site randomized tral aims to test methods of increasing adoption and integration of blood glucose monitoring into electronic medical records, and to measure the impact of wide-scale adoption on health status of patients with diabetes. To investigate determinants of adoption, the research will combine and test doctor and patient focused approaches to encouraging patient use of blood glucose flow sheets through the online patient portal, MyChart. Adoption will be measured on both the extensive and intensive margin: the number of patients who enter data into the flowsheets at all during the study period, and the mean number of entries per patient during the study period. Conditional on statistically significant increases in adoption, the study will examine corresponding intent-to-treat effects on patient A1c, and consider other indicators of possible mechanisms through which A1c improves or does not improve.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1: Control | No Intervention | A randomly selected half of primary care practices in the study sample at Inova Health Care Services will not receive any intervention and patients/physicians located at these practices will continue with business as usual. | |
| 2a: Practice Orientation- No Reminder | Experimental | In the other randomly selected half of primary care practices in the study sample at Inova Health Care Services, practices will be encouraged to batch order blood glucose flowsheets for all patients with diabetes with active MyChart accounts. The research team will contact physicians and practice managers with an explanation of the initiative and instructions for completing batch orders and viewing entries through the system. Additionally, providers will be given a template for a secure smart-text message to send to all patients receiving the flowsheets, instructing them to enter data for the study period. The secure message will also provide them with information on how to enter data, and on the benefits of tracking blood glucose. Of this group of practices, patients will be divided at the individual level into 4 reminder groups. Arm 2a will receive no additional reminder messaging to enter glucose measurements in the electronic flowsheets. |
|
| 2b: Practice Orientation- Standard Reminder | Experimental | Practices will be encouraged to batch order blood glucose flowsheets for all patients with diabetes with active MyChart accounts. The research team will contact physicians and practice managers with an explanation of the initiative and instructions for completing batch orders and viewing entries through the system. Additionally, providers will be given a template for a secure smart-text message to send to all patients receiving the flowsheets, instructing them to enter data for the study period. The secure message will also provide them with information on how to enter data, and on the benefits of tracking blood glucose. Of this group of practices, patients will be divided at the individual level into 4 reminder groups. Arm 2b will receive generic biweekly reminders, addressed from Inova Medical Group, to enter glucose measurements in the electronic flowsheets. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Practice Orientation | Behavioral | Practices will be encouraged to batch order blood glucose flowsheets for all patients with diabetes with active MyChart accounts. This will allow diabetic patients at these practices to enter any self-monitored glucose measurements. The research team will contact physicians and practice managers with an explanation of the initiative and instructions for completing batch orders and viewing entries through the system. Additionally, providers will be given a template for a secure smart-text message to send to all patients receiving the flowsheets, instructing them to enter data for the study period. The secure message will also provide them with information on how to enter data, and on the benefits of tracking blood glucose. |
| Measure | Description | Time Frame |
|---|---|---|
| Count of Participants Entering Flowsheet Data During Measurement Period, Extensive Margin | Count of participants that entered data to an electronic glucose flowsheet during the measurement period (Count of participants determined with a binary aggregation method; 1= Participant used Flow Sheet at least once during measurement period; 0= Participant did not use Flow Sheet during Measurement Period) | (1-14) weeks after initial practice orientation |
| Participant A1c Test Results (as Percent A1c) at 26 Weeks | Percent A1c represents average blood sugar levels as determined by Hemoglobin A1c (HbA1c) test. The HbA1c test measures what percentage of hemoglobin proteins in blood are glycated. The most recent and available HbA1c test value (percent A1c) in electronic medical records at appropriate time period was used. | 26 weeks after initial practice orientation |
| Measure | Description | Time Frame |
|---|---|---|
| Count of Participants Entering Flowsheet Data During Measurement Period, Extensive Margin | Count of participants that entered data to an electronic glucose flowsheet during the measurement period (Count of participants determined with a binary aggregation method; 1= Participant used Flow Sheet at least once during measurement period; 0= Participant did not use Flow Sheet during Measurement Period) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Allyson B Root, MS | General Services Administration, UC Berkeley | Principal Investigator |
| Season Majors, MSN,RN | Inova Health Care Services | Principal Investigator |
| Mary Ann Friesen, PhD | Inova Health Care Services | Principal Investigator |
| Christopher P Connolly, MD | Inova Health Care Services | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Inova Heath System | Falls Church | Virginia | 22042 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
20 primary care practices were randomly assigned to treatment (10 practices, 3411 patients) and control (10 practices, 3641 patients). Participants at treated primary care practices whose providers placed flow sheet orders (2182 patients total) were assigned to 1 of 4 reminder message groups to encourage utilization of the flow sheets. Assignment to reminder groups was determined alphabetically by the first letter of participant's last name.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | 1: Control | A randomly selected half of primary care practices in the study sample at Inova Health Care Services will not receive any intervention and patients/physicians located at these practices will continue with business as usual. |
| FG001 | Experimental | Participants at treated primary care practices whose doctors placed flow sheet orders (2182 patients total) were assigned to 1 of 4 reminder message groups to encourage utilization of the flow sheets |
| FG002 | 2a: Participants in the Practice Orientation- No Reminder | Participants assigned to this group will receive no additional reminder messaging to enter glucose measurements in the electronic flowsheets. |
| FG003 | 2b: Participants in the Practice Orientation- Standard Reminder | Participants in this group will receive generic biweekly reminders, addressed from Inova Medical Group, to enter glucose measurements in the electronic flowsheets |
| FG004 | 2c: Participants in the Practice Orientation- Gift Card Reminder | Participants in this group will receive generic biweekly reminders to enter data, addressed from Inova Medical Group, that will also notify that the patient will be entered to win a $50 gift card for each day entering data. |
| FG005 | 2d: Participants in the Practice Orientation- Physician Reminder | Participants in this group will receive biweekly reminders, addressed from their physician, encouraging them to enter glucose measurements in the electronic flowsheets (Note that though messages will be addressed from physician, they will be sent by Inova IT). |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary Care Practices Randomization |
| |||||||||||||
| Participant Randomization |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | 1: Control | A randomly selected half of primary care practices in the study sample at Inova Health Care Services will not receive any intervention and patients/physicians located at these practices will continue with business as usual. |
| BG001 | 2a: Participants in the Practice Orientation- No Reminder |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Count of Participants Entering Flowsheet Data During Measurement Period, Extensive Margin | Count of participants that entered data to an electronic glucose flowsheet during the measurement period (Count of participants determined with a binary aggregation method; 1= Participant used Flow Sheet at least once during measurement period; 0= Participant did not use Flow Sheet during Measurement Period) | Posted | Count of Participants | Participants | (1-14) weeks after initial practice orientation |
|
Not provided
Death, serious adverse events, and other (non-serious adverse events) were not assessed for this study.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | 1: Control | A randomly selected half of primary care practices in the study sample at Inova Health Care Services will not receive any intervention and patients/physicians located at these practices will continue with business as usual. |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Mattie Toma | Office of Evaluation Sciences, General Services Administration | 859-621-0517 | mattie.toma@gsa.gov |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Feb 21, 2019 | Nov 10, 2022 | Prot_SAP_001.pdf |
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| FED |
Primary care practices will be assigned to a provider-side treatment (physician orientation) or to control. Within treatment assigned practices, individual patients will be assigned to one of four reminder messaging groups (one of which is no messaging).
Not provided
Not provided
Not provided
Not provided
|
| 2c: Practice Orientation- Gift Card Reminder | Experimental | Practices will be encouraged to batch order blood glucose flowsheets for all patients with diabetes with active MyChart accounts. The research team will contact physicians and practice managers with an explanation of the initiative and instructions for completing batch orders and viewing entries through the system. Additionally, providers will be given a template for a secure smart-text message to send to all patients receiving the flowsheets, instructing them to enter data for the study period. The secure message will also provide them with information on how to enter data, and on the benefits of tracking blood glucose. Of this group of practices, patients will be divided at the individual level into 4 reminder groups. Arm 2c will receive generic biweekly reminders to enter data, addressed from Inova Medical Group, that will also notify that the patient will be entered to win a $50 gift card for each day entering data. |
|
| 2d: Practice Orientation- Physician Reminder | Experimental | Practices will be encouraged to batch order blood glucose flowsheets for all patients with diabetes with active MyChart accounts. The research team will contact physicians and practice managers with an explanation of the initiative and instructions for completing batch orders and viewing entries through the system. Additionally, providers will be given a template for a secure smart-text message to send to all patients receiving the flowsheets, instructing them to enter data for the study period. The secure message will also provide them with information on how to enter data, and on the benefits of tracking blood glucose. Of this group of practices, patients will be divided at the individual level into 4 reminder groups. Arm 2d will receive biweekly reminders, addressed from their physician, encouraging them to enter glucose measurements in the electronic flowsheets (Note that though messages will be addressed from physician, they will be sent by Inova IT). |
|
|
| Standard Reminder | Behavioral | Patients receive generic biweekly reminders, addressed from Inova Medical Group, to enter glucose measurements in the electronic flowsheets |
|
| Gift Card Reminder | Behavioral | Patients receive generic biweekly reminders, addressed from Inova Medical Group, to enter glucose measurements in the electronic flowsheets. In these reminders, they will also be notified that that they will be entered to win a $50 gift card for each day entering data. |
|
| Physician Reminders | Behavioral | Patients receive biweekly reminders, addressed from their physician, encouraging them to enter glucose measurements in the electronic flowsheets (Note that though messages will be addressed from physician, they will be sent by Inova IT) |
|
| Beginning of week 15 to 26 weeks after initial practice orientation |
| Number of Days Participant Used Flowsheet, Intensive | The total number of days of participant use of the electronic glucose flowsheet during the measurement period. A day of Participant use of electronic glucose flowsheet is defined here as as day (24 hours) in which the participant performed an entry into an electronic glucose flowsheet. | (1-14); (15-26) weeks after initial practice orientation |
| Count of Participants With an Open Physician Order for Electronic Glucose Flowsheet | Count of participants that have an open physician order for electronic glucose flowsheet end of the measurement period (Count of participants determined with a binary aggregation method; 1= Participant had an open physician order for electronic Glucose Flow Sheet at end of measurement period; 0= Participant did not have an open physician order for electronic Glucose Flow Sheet at end of measurement period) | at 14 and 26 weeks after initial practice orientation |
| Number of Days Since Last HbA1c Test | The total number of days that elapsed since participant last had and HbA1c test. The number of days was measured by the number of days that passed from the date of the most recent HbA1c test in the Electronic Medical Record and the date of the data extraction at the specified time point. | 14; 26 weeks after initial practice orientation |
| Participant A1c Test Results (as Percent A1c) at 14 Weeks | Percent A1c represents average blood sugar levels as determined by Hemoglobin A1c (HbA1c) test. The HbA1c test measures what percentage of hemoglobin proteins in blood are glycated. The most recent and available HbA1c test value (percent A1c) in electronic medical records at appropriate time period was used | 14 weeks after initial practice orientation |
| Count of Participants With Improvement of HbA1c Test Results | Count of participants with improved HbA1c test result values in most recent Electronic Medical Record (EMR) during measurement period as compared to HbA1c test value at baseline. (Count of participants determined with a binary aggregation method; 1= Participant Improved, most recent A1c test value less than baseline A1c test value; 0= Participant did not Improve; most recent A1c test value greater than or equal to baseline A1c test value) Improvement of HbA1c test results is defined as a reduction of the most recent and available HbA1c test value (a lower percent A1c) in the EMR at appropriate time period relative to the baseline. Percent A1c represents average blood sugar levels as determined by Hemoglobin A1c (HbA1c) test The HbA1c test measures what percentage of hemoglobin proteins in blood are glycated. Higher percent A1c levels are associated with poor blood sugar control and increased risk of of diabetes-related complications. | 14; 26 weeks after initial practice orientation |
| Count of Participants With Percent A1c Below Benchmark of 7 | Count of participants with most recent HbA1c test value (percent A1c) in Electronic Medical Records below target benchmark of 7 at appropriate time point (Count of participants determined with a binary aggregation method; 1= Participant HbA1c test value less than 7; 0= Participant Hb1Ac test value greater than or equal to 7). Percent A1c represents average blood sugar levels as determined by Hemoglobin A1c (HbA1c) test. The HbA1c test measures what percentage of hemoglobin proteins in blood are glycated. A percent A1c level less than 7 is a common treatment target and is associated with with a lower risk of diabetes-related complications. | 14; 26 weeks after initial practice orientation |
| Total Secure Messages Sent by Participant | Total number of messages sent by participant via MyChart Electronic medical records system during the measurement period | (1-14); (15-26) weeks after initial practice orientation |
| Total Secure Messages Sent by Patient to Primary Care Provider | Total number of MyChart messages sent by patient to the Primary Care Provider (PCP) during the measurement period. Not reported separately from Total number of messages sent by patient, so outcomes not reported here. | (1-14); (15-26) weeks after initial practice orientation |
| Total Secure Messages Sent by PCP to Patient | Total number of MyChart messages sent by PCP to the patient during the measurement period | (1-14); (15-26) weeks after initial practice orientation |
| Total Number of Participant Phone Appointments | Total number of participant phone appointments during the measurement period | (1-14); (1-26) weeks after initial practice orientation |
| Total Number of Participant In-person Appointments | Total number of participant in-person appointments during the measurement period | (1-14); (1-26) weeks after initial practice orientation |
| Count of Participants With Changes to Active Medication List | Count of Participants with Changes (Any; Addition; Removal) to list of active medications in EMR during measurement period. Active medication lists is comprised of prescription ordered medications for participants. Count of participants determined with a binary aggregation method: Any Change is defined as medications added or removed from active list ( 1= Participant had medications added to or removed from active medication list; 0= Participant did not have medication added to or removed from active medication list). Medications Added is defined as the addition of medications to active medication list ( 1= Participant had medications added to active medication list; 0= Participant did not have medications added to active medication list). Medications Removed is defined as the removal of medications to active medication list ( 1= Participant had medications removed from active medication list; 0= Participant did not have medications removed from active medication list). | (1-14); (1-26) weeks after initial practice orientation |
| Prescription Orders | Number of prescription ordered medications for participant during measurement period (Total all; Total new/non-refill; Total diabetes related) | (1-14); (1-26) weeks after initial practice orientation |
| Flowsheet Entry Values (Descriptive) | Value of blood glucose entered into flowsheet (descriptive analysis). No systematic outcomes recorded to report. | 2; 4; 6; 8; 10; 12; 14; 18; 22; 26 weeks after initial orientation meeting |
| COMPLETED | Primary care practices in the experimental group were excluded as they did not have any participants with the corresponding first letter of the last names used for participant assignment. |
|
| NOT COMPLETED |
|
Participants assigned to this group will receive no additional reminder messaging to enter glucose measurements in the electronic flowsheets. |
| BG002 | 2b: Participants in the Practice Orientation- Standard Reminder | Participants in this group will receive generic biweekly reminders to enter data, addressed from Inova Medical Group, that will also notify that the patient will be entered to win a $50 gift card for each day entering data. |
| BG003 | 2c: Participants in the Practice Orientation- Gift Card Reminder | Participants in this group will receive generic biweekly reminders to enter data, addressed from Inova Medical Group, that will also notify that the patient will be entered to win a $50 gift card for each day entering data. |
| BG004 | 2d: Participants in the Practice Orientation- Physician Reminder | Participants in this group will receive biweekly reminders, addressed from their physician, encouraging them to enter glucose measurements in the electronic flowsheets (Note that though messages will be addressed from physician, they will be sent by Inova IT). |
| BG005 | Total | Total of all reporting groups |
| years |
|
| Sex/Gender, Customized | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Race/Ethnicity reported as Hispanic; White, Non-Hispanic; or Other, Unknown or not Reported due to limitations in the data available to report. Data available for analyses is dependent on information available in the Electronic Medical Records (EMR) and the technical limitations of extracting and compiling datasets from the EMR. Missing, unknown, or multiple ethnicity values were not distinguishable due the limitations and are reported as one combined category. | Count of Participants | Participants |
|
| Percent A1c, Baseline | Percent A1c represents average blood sugar levels as determined by Hemoglobin A1c (HbA1c) test | Data reported only for participants with available A1c test results in their Electronic Medical Record (EMR) during appropriate timeframe. Participants with no test results or with missing values in their EMR at appropriate timepoint were not included in analysis. | Mean | Standard Deviation | Percent A1c |
|
Participants assigned to this group will receive no additional reminder messaging to enter glucose measurements in the electronic flowsheets. |
| OG002 | 2b: Practice Orientation- Standard Reminder | Participants in this group will receive generic biweekly reminders, addressed from Inova Medical Group, to enter glucose measurements in the electronic flowsheets |
| OG003 | 2c: Practice Orientation- Gift Card Reminder | Participants in this group will receive generic biweekly reminders to enter data, addressed from Inova Medical Group, that will also notify that the patient will be entered to win a $50 gift card for each day entering data. |
| OG004 | 2d: Practice Orientation- Physician Reminder | Participants in this group will receive biweekly reminders, addressed from their physician, encouraging them to enter glucose measurements in the electronic flowsheets (Note that though messages will be addressed from physician, they will be sent by Inova IT). |
|
|
| Primary | Participant A1c Test Results (as Percent A1c) at 26 Weeks | Percent A1c represents average blood sugar levels as determined by Hemoglobin A1c (HbA1c) test. The HbA1c test measures what percentage of hemoglobin proteins in blood are glycated. The most recent and available HbA1c test value (percent A1c) in electronic medical records at appropriate time period was used. | Data reported only for participants with available A1c test results in their Electronic Medical Record (EMR) during appropriate timeframe. Participants with no test results or with missing values in their EMR at appropriate timepoint were not included in analysis. | Posted | Mean | Standard Deviation | Percent A1c | 26 weeks after initial practice orientation |
|
|
|
| Secondary | Count of Participants Entering Flowsheet Data During Measurement Period, Extensive Margin | Count of participants that entered data to an electronic glucose flowsheet during the measurement period (Count of participants determined with a binary aggregation method; 1= Participant used Flow Sheet at least once during measurement period; 0= Participant did not use Flow Sheet during Measurement Period) | Posted | Count of Participants | Participants | Beginning of week 15 to 26 weeks after initial practice orientation |
|
|
|
| Secondary | Number of Days Participant Used Flowsheet, Intensive | The total number of days of participant use of the electronic glucose flowsheet during the measurement period. A day of Participant use of electronic glucose flowsheet is defined here as as day (24 hours) in which the participant performed an entry into an electronic glucose flowsheet. | Posted | Mean | Standard Deviation | days | (1-14); (15-26) weeks after initial practice orientation |
|
|
|
| Secondary | Count of Participants With an Open Physician Order for Electronic Glucose Flowsheet | Count of participants that have an open physician order for electronic glucose flowsheet end of the measurement period (Count of participants determined with a binary aggregation method; 1= Participant had an open physician order for electronic Glucose Flow Sheet at end of measurement period; 0= Participant did not have an open physician order for electronic Glucose Flow Sheet at end of measurement period) | Posted | Count of Participants | Participants | at 14 and 26 weeks after initial practice orientation |
|
|
|
| Secondary | Number of Days Since Last HbA1c Test | The total number of days that elapsed since participant last had and HbA1c test. The number of days was measured by the number of days that passed from the date of the most recent HbA1c test in the Electronic Medical Record and the date of the data extraction at the specified time point. | Data reported only for participants with available A1c test results in their Electronic Medical Record (EMR) during appropriate timeframe. Participants with no test results in their EMR at appropriate timepoint were not included in analysis | Posted | Mean | Standard Deviation | days | 14; 26 weeks after initial practice orientation |
|
|
|
| Secondary | Participant A1c Test Results (as Percent A1c) at 14 Weeks | Percent A1c represents average blood sugar levels as determined by Hemoglobin A1c (HbA1c) test. The HbA1c test measures what percentage of hemoglobin proteins in blood are glycated. The most recent and available HbA1c test value (percent A1c) in electronic medical records at appropriate time period was used | Data reported only for participants with available A1c test results in their Electronic Medical Record (EMR) during appropriate timeframe. Participants with no test results or with missing values in their EMR at appropriate timepoint were not included in analysis. | Posted | Mean | Standard Deviation | Percent A1c | 14 weeks after initial practice orientation |
|
|
|
| Secondary | Count of Participants With Improvement of HbA1c Test Results | Count of participants with improved HbA1c test result values in most recent Electronic Medical Record (EMR) during measurement period as compared to HbA1c test value at baseline. (Count of participants determined with a binary aggregation method; 1= Participant Improved, most recent A1c test value less than baseline A1c test value; 0= Participant did not Improve; most recent A1c test value greater than or equal to baseline A1c test value) Improvement of HbA1c test results is defined as a reduction of the most recent and available HbA1c test value (a lower percent A1c) in the EMR at appropriate time period relative to the baseline. Percent A1c represents average blood sugar levels as determined by Hemoglobin A1c (HbA1c) test The HbA1c test measures what percentage of hemoglobin proteins in blood are glycated. Higher percent A1c levels are associated with poor blood sugar control and increased risk of of diabetes-related complications. | Data reported only for participants with available A1c test results in their Electronic Medical Record (EMR) during appropriate timeframes. Participants with no test results or with missing values in their EMR at appropriate timepoints were not included in analysis. | Posted | Count of Participants | Participants | 14; 26 weeks after initial practice orientation |
|
|
|
| Secondary | Count of Participants With Percent A1c Below Benchmark of 7 | Count of participants with most recent HbA1c test value (percent A1c) in Electronic Medical Records below target benchmark of 7 at appropriate time point (Count of participants determined with a binary aggregation method; 1= Participant HbA1c test value less than 7; 0= Participant Hb1Ac test value greater than or equal to 7). Percent A1c represents average blood sugar levels as determined by Hemoglobin A1c (HbA1c) test. The HbA1c test measures what percentage of hemoglobin proteins in blood are glycated. A percent A1c level less than 7 is a common treatment target and is associated with with a lower risk of diabetes-related complications. | Data reported only for participants with available A1c test results in their Electronic Medical Record (EMR) during appropriate timeframe. Participants with no test results or with missing values in their EMR at appropriate timepoint were not included in analysis. | Posted | Count of Participants | Participants | 14; 26 weeks after initial practice orientation |
|
|
|
| Secondary | Total Secure Messages Sent by Participant | Total number of messages sent by participant via MyChart Electronic medical records system during the measurement period | Posted | Mean | Standard Deviation | number of messages | (1-14); (15-26) weeks after initial practice orientation |
|
|
|
| Secondary | Total Secure Messages Sent by Patient to Primary Care Provider | Total number of MyChart messages sent by patient to the Primary Care Provider (PCP) during the measurement period. Not reported separately from Total number of messages sent by patient, so outcomes not reported here. | Data not collected. | Posted | (1-14); (15-26) weeks after initial practice orientation |
|
|
| Secondary | Total Secure Messages Sent by PCP to Patient | Total number of MyChart messages sent by PCP to the patient during the measurement period | Data not collected. | Posted | (1-14); (15-26) weeks after initial practice orientation |
|
|
| Secondary | Total Number of Participant Phone Appointments | Total number of participant phone appointments during the measurement period | Posted | Mean | Standard Deviation | number of phone appointments | (1-14); (1-26) weeks after initial practice orientation |
|
|
|
| Secondary | Total Number of Participant In-person Appointments | Total number of participant in-person appointments during the measurement period | Posted | Mean | Standard Deviation | number of appointments | (1-14); (1-26) weeks after initial practice orientation |
|
|
|
| Secondary | Count of Participants With Changes to Active Medication List | Count of Participants with Changes (Any; Addition; Removal) to list of active medications in EMR during measurement period. Active medication lists is comprised of prescription ordered medications for participants. Count of participants determined with a binary aggregation method: Any Change is defined as medications added or removed from active list ( 1= Participant had medications added to or removed from active medication list; 0= Participant did not have medication added to or removed from active medication list). Medications Added is defined as the addition of medications to active medication list ( 1= Participant had medications added to active medication list; 0= Participant did not have medications added to active medication list). Medications Removed is defined as the removal of medications to active medication list ( 1= Participant had medications removed from active medication list; 0= Participant did not have medications removed from active medication list). | Posted | Count of Participants | Participants | (1-14); (1-26) weeks after initial practice orientation |
|
|
|
| Secondary | Prescription Orders | Number of prescription ordered medications for participant during measurement period (Total all; Total new/non-refill; Total diabetes related) | Posted | Mean | Standard Deviation | number of orders | (1-14); (1-26) weeks after initial practice orientation |
|
|
|
| Secondary | Flowsheet Entry Values (Descriptive) | Value of blood glucose entered into flowsheet (descriptive analysis). No systematic outcomes recorded to report. | Data not collected. | Posted | 2; 4; 6; 8; 10; 12; 14; 18; 22; 26 weeks after initial orientation meeting |
|
|
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| EG001 | 2a: Practice Orientation- No Reminder | Participants assigned to this group will receive no additional reminder messaging to enter glucose measurements in the electronic flowsheets. | 0 | 0 | 0 | 0 | 0 | 0 |
| EG002 | 2b: Practice Orientation- Standard Reminder | Participants in this group will receive generic biweekly reminders, addressed from Inova Medical Group, to enter glucose measurements in the electronic flowsheets | 0 | 0 | 0 | 0 | 0 | 0 |
| EG003 | 2c: Practice Orientation- Gift Card Reminder | Participants in this group will receive generic biweekly reminders to enter data, addressed from Inova Medical Group, that will also notify that the patient will be entered to win a $50 gift card for each day entering data. | 0 | 0 | 0 | 0 | 0 | 0 |
| EG004 | 2d: Practice Orientation- Physician Reminder | Participants in this group will receive biweekly reminders, addressed from their physician, encouraging them to enter glucose measurements in the electronic flowsheets (Note that though messages will be addressed from physician, they will be sent by Inova IT). | 0 | 0 | 0 | 0 | 0 | 0 |
Not provided
Not provided
| Female |
|
| White, Non-Hispanic |
|
| Other, Unknown, or Not reported |
|
| Weeks 15-26 |
|
| Week 26 |
|
|
| Week 26 |
|
|
|
| At Week 26 |
|
|
|
| At Week 26 |
|
|
| Weeks 15-26 |
|
| Weeks 1-26 |
|
| Weeks 1-26 |
|
| Any Change - Weeks 1-26 |
|
| Medication Added - Weeks 1-14 |
|
| Medication Added - Weeks 1-26 |
|
| Medication Removed - Weeks 1-14 |
|
| Medication Removed - Weeks 1-26 |
|
| Number of Total Prescription Orders - Weeks 1-26 |
|
| Number of Non-Refill Orders - Weeks 1-14 |
|
| Number of Non-Refill Orders - Weeks 1-26 |
|
| Number of Diabetes Related Prescription Orders - Weeks 1-14 |
|
| Number of Diabetes Related Prescription Orders - Weeks 1-26 |
|